Explore Brian Singerman's new fund GPx and investment strategy after leaving Founders Fund. What frontier tech bets define his next chapter.
Brian Singerman's departure from Founders Fund in December 2024 marked one of the most significant moves in venture capital this year. After two decades building one of the most formidable portfolios in tech-from Airbnb and Stripe to SpaceX and Anduril-Singerman stepped back as a general partner. But he didn't retire. Instead, he launched GPx, a new fund raising over $500 million with backing from Peter Thiel himself, signaling a fundamental shift in how he plans to deploy capital and influence the venture ecosystem.
For founders, operators, and investors tracking the market, this transition carries real implications. Singerman's moves have historically been bellwethers for emerging tech trends. His early bets on defense tech through Anduril, his healthcare thesis via Oscar Health and Affirm, and his frontier tech conviction have shaped which sectors attract institutional capital. Understanding what he's building now-and why he left Founders Fund-offers a window into the next wave of venture strategy.
This article breaks down Singerman's career arc, the mechanics of his new fund, and what his portfolio signals about the future of capital allocation in 2025 and beyond.
Brian Singerman joined Founders Fund in 2005 as an early partner, arriving when the firm was still establishing its contrarian reputation. Over nearly two decades, he became one of the most prolific investors in the fund's portfolio, backing companies that would define multiple generations of tech.
His Founders Fund wins are legendary. He was an early investor in Airbnb when the company was still renting air mattresses in Brooklyn apartments. He backed Stripe when online payments seemed commoditized. He saw the potential in SpaceX when aerospace was a graveyard of failed startups. More recently, he doubled down on defense tech, becoming one of the earliest institutional believers in Anduril, the defense intelligence startup that has since become a multi-billion-dollar powerhouse.
What made Singerman distinctive within Founders Fund was his willingness to think across multiple domains simultaneously. While the fund maintained its core thesis around frontier technology-companies solving hard problems in physics, biology, and engineering-Singerman also invested heavily in healthcare, fintech, and software. He backed Oscar Health, a health insurance startup using data and technology to disrupt a $1.5 trillion industry. He led investments in Affirm, which reimagined consumer lending. He invested in Wish, the e-commerce platform, and Asana, the work management tool.
This breadth was intentional. In interviews, Singerman has explained that the best venture investors don't restrict themselves to a single narrative. They look for founders with conviction, technology that actually works, and markets large enough to matter. His portfolio reflected that philosophy: it wasn't ideologically pure, but it was consistently contrarian and consistently right.
By the time he stepped back as general partner, Singerman had become one of the most successful venture investors of his generation. His returns spoke for themselves, and his pattern recognition-the ability to spot inflection points before they become obvious-made him invaluable to Founders Fund's brand and decision-making.
Yet something shifted. In late 2024, Singerman announced he was transitioning to partner emeritus status, effectively stepping back from day-to-day partnership at the firm. The move surprised many in the industry, but it also made sense: Singerman had accomplished what most venture investors only dream of, and he was ready for a different kind of challenge.
Singerman's new vehicle, GPx, is not a traditional venture fund. Instead, it's a hybrid structure designed to serve two constituencies simultaneously: emerging venture fund managers and growth-stage companies seeking later-stage capital.
The fund is raising over $500 million, a significant amount that signals serious institutional backing. Notably, Peter Thiel is a major backer, which tells you something important about the fund's philosophy and reach. Thiel has historically been the most contrarian voice in venture capital, backing companies like Facebook, Airbnb, and SpaceX when conventional wisdom said they were too risky or too niche. His involvement with GPx suggests the fund will maintain that same willingness to bet against consensus.
But here's where GPx differs from traditional venture funds: Singerman is positioning it as a platform for emerging venture capitalists. Rather than simply deploying capital directly into startups, GPx will also back new fund managers-the next generation of venture investors who are starting their own firms. This is a significant strategic choice.
Why does this matter? Because the venture capital industry has become increasingly concentrated. A handful of mega-funds-Andreessen Horowitz, Sequoia, Benchmark, and a few others-control the majority of capital and deal flow. For emerging fund managers, raising a first fund is brutally difficult. Limited partners (LPs) want track records, and you can't build a track record without capital. It's a chicken-and-egg problem that locks out talent and diversity from the venture ecosystem.
GPx is designed to solve that problem, at least partially. By backing emerging fund managers, Singerman is essentially creating a feeder system for the next wave of venture capital. These new managers will have access to Singerman's deal flow, his pattern recognition, and his network. In return, GPx gets exposure to their investments and the upside from their eventual success.
This model also aligns with a broader trend in venture capital toward operator-led investing. Operators-founders, executives, and investors with deep domain expertise-are increasingly starting their own funds or co-investing alongside traditional VCs. They bring pattern recognition, credibility with founders, and the ability to add value beyond capital. By backing these emerging managers, Singerman is positioning himself at the center of this shift.
One of the clearest signals about Singerman's investment philosophy comes from his bet on Anduril, the defense intelligence startup founded by Palmer Luckey. This investment is instructive because it shows how Singerman thinks about structural shifts in the economy and geopolitics.
Anduril is not a traditional defense contractor. It doesn't build weapons systems or manage supply chains for the military-industrial complex. Instead, it builds autonomous systems and AI-powered intelligence platforms for defense applications. The company has grown to a multi-billion-dollar valuation by solving a specific problem: the U.S. military and intelligence agencies need better ways to process sensor data and make decisions in real time.
Singerman's conviction in Anduril reflects a broader thesis about the future of defense spending and technological advantage. As geopolitical tensions rise-particularly with China-the U.S. government is increasingly willing to fund technology startups that can help maintain military superiority. This is not a niche market; it's a structural shift in how the government allocates hundreds of billions of dollars annually.
This thesis also connects to the broader frontier tech narrative that Singerman has always championed. Defense tech is hard tech. It requires solving difficult engineering problems, often at the edge of what's currently possible. It attracts world-class talent. And it has clear, large-scale customers willing to pay for solutions. These are exactly the characteristics Singerman looks for in investments.
What's notable is that Singerman's defense tech thesis is becoming increasingly mainstream. Andreessen Horowitz's $20 billion AI fund explicitly includes defense and national security as a focus area. Other major VCs are launching dedicated defense tech funds. The idea that venture capital should fund frontier defense technology is no longer contrarian; it's becoming consensus.
But Singerman was there first. His early bet on Anduril-made when defense tech was still considered unsexy by most venture investors-demonstrates the pattern recognition that made him valuable at Founders Fund and will likely make GPx successful.
While Singerman is known for frontier tech bets, his healthcare and biotech investments reveal another dimension of his thinking. These are not the flashy, growth-at-all-costs companies that dominate venture headlines. Instead, they're companies solving structural problems in healthcare using technology and data.
Oscar Health is the clearest example. Health insurance is one of the most regulated, entrenched industries in America. It's also deeply unpopular-most people hate their insurance companies. Yet Oscar Health has built a modern health insurance company using data science, user experience, and technology to compete against incumbents that have been in business for decades.
This investment reveals something important about Singerman's approach: he's willing to bet on unglamorous sectors if the underlying technology and market dynamics support it. Healthcare is massive-it's roughly 18% of U.S. GDP-and it's ripe for disruption by technology. Traditional venture investors often overlook healthcare because it's regulated and the sales cycles are long. But those same factors create barriers to entry that protect successful entrants from competition.
Similarly, Singerman's investment in Affirm-the buy-now-pay-later fintech-shows his willingness to back companies that solve real consumer problems, even if they're not the most exciting narratives. Affirm fundamentally changed how consumers finance purchases online, and it did so by building better technology and underwriting models than traditional consumer finance companies.
These investments matter because they signal that Singerman's thesis is not narrowly focused on AI, defense, or space. Instead, he's looking for companies that solve structural problems in large markets using technology. That could be healthcare, fintech, or any other sector where incumbents are vulnerable and technology can create a sustainable advantage.
For founders raising capital, this is an important signal. It means that investors like Singerman are willing to fund unglamorous sectors if the fundamental thesis is sound. It also means that the best venture investors are not chasing trends; they're identifying structural shifts in the economy and backing founders who can exploit those shifts.
The question many in the industry have asked is: why did Singerman leave Founders Fund? The firm is still one of the most successful venture capital firms in the world. Singerman was one of its most successful partners. Why walk away?
The answer likely involves several factors. First, Singerman has accomplished what most venture investors only dream of. He's backed multiple billion-dollar companies. He's generated exceptional returns for LPs. He's influenced the direction of entire sectors. At a certain point, the marginal return on staying at a large partnership diminishes. You've already won the game.
Second, the structure of large venture partnerships can be constraining for someone with Singerman's track record and vision. At Founders Fund, Singerman was one of several partners, each with their own thesis and portfolio. At GPx, he has the freedom to build exactly the fund he wants, focused on exactly the thesis he believes in.
Third, the venture capital industry itself is changing. The era of the mega-fund-where a single partnership manages $20 billion or more-is creating opportunities for smaller, more specialized funds. GPx's hybrid model, combining direct investments with backing for emerging fund managers, is a bet on this structural shift. Singerman likely saw that the future of venture capital would be more distributed, with capital flowing through multiple vehicles rather than concentrated in a handful of mega-funds.
Finally, there's the question of legacy. Singerman has already built a legendary track record at Founders Fund. His next chapter is about building something new: a platform that supports the next generation of venture investors. This is a different kind of legacy-not just the companies you back, but the investors you enable and the ecosystem you build.
GPx is not just Singerman's new fund; it's a signal about the future of venture capital more broadly. Several trends are evident from the fund's structure and thesis.
First, the rise of operator-led investing. Operators are increasingly starting their own funds or co-investing alongside traditional VCs. This is because operators bring pattern recognition, credibility, and the ability to add value beyond capital. By backing emerging fund managers, Singerman is positioning himself at the center of this trend. He's essentially building a platform for operator-led venture capital.
Second, the importance of frontier tech and hard problems. Despite the dominance of AI in venture headlines, Singerman's thesis remains focused on companies solving genuinely hard problems. This includes AI, but also defense, healthcare, biotech, and other sectors where technology can create sustainable competitive advantages. The future of venture capital will likely be split between AI-focused funds and frontier tech funds focused on hard problems.
Third, the decentralization of venture capital. The era of mega-funds controlling deal flow is ending. Instead, capital will flow through multiple vehicles: traditional VCs, emerging fund managers, operator-led funds, and corporate venture arms. GPx is positioned to benefit from this decentralization by backing the emerging fund managers who will control increasing amounts of capital.
Fourth, the importance of founder-investor fit. As venture capital becomes more distributed, founder-investor fit becomes more important. Founders need to understand what different investors bring beyond capital. Singerman's track record suggests he brings pattern recognition, credibility, and access to networks. These are the intangibles that matter most as capital becomes more abundant.
For founders currently raising capital, Singerman's transition offers several lessons.
First, understand the investor's thesis. Singerman is not a generalist investor. He has a specific thesis about frontier technology, hard problems, and structural shifts in the economy. Founders who understand this thesis and can articulate how their company fits into it are more likely to attract his attention and capital. The lesson: know your investor's thesis and be able to explain why your company is a fit.
Second, build for the long term. Many of Singerman's best investments took years to mature. Airbnb, Stripe, and SpaceX were all contrarian bets at the time they were funded. They required patient capital and investors willing to hold through periods of doubt. If you're building a frontier tech company, you need investors who understand this timeline and are willing to commit for the long haul.
Third, focus on solving real problems. Singerman's investments span multiple sectors, but they all share a common characteristic: they solve real problems in large markets. Whether it's healthcare, fintech, or defense, the best investments are those that address genuine structural inefficiencies. If you're raising capital, be able to articulate the real problem you're solving and why existing solutions are inadequate.
Fourth, understand cap table and funding mechanics. As you raise capital, you'll encounter different funding structures: traditional equity rounds, SAFEs, convertible notes, and more. Understanding how these work and how they affect your cap table is essential. Singerman's new fund structure-backing both companies and emerging fund managers-reflects a sophisticated understanding of how capital flows through the venture ecosystem. As a founder, you should have a similar understanding of how your funding rounds will affect your ability to raise in the future.
For more detailed guidance on these topics, Capitaly offers daily insights on venture, fundraising, valuations, and startup life. Founders can learn about common pitch mistakes that investors see every week, how to think about startup valuations, and what deep tech startup ideas are gaining traction in 2025.
Looking ahead, Singerman's move to GPx will likely have ripple effects throughout the venture ecosystem. First, it will accelerate the trend toward smaller, more specialized funds. If one of the most successful venture investors is leaving a mega-fund to start something new, other successful investors will likely follow. This will create more opportunities for founders, as capital becomes more distributed.
Second, it will increase focus on frontier technology and hard problems. As AI becomes more commoditized and mega-funds compete for the same AI companies, investors like Singerman will increasingly focus on other sectors where technology can create sustainable advantages. This includes defense, healthcare, biotech, climate, and other hard tech areas.
Third, it will reshape how venture capital backs emerging fund managers. GPx's hybrid model-combining direct investments with backing for emerging fund managers-could become a template for other successful investors. This would democratize access to capital for new fund managers and create more diversity in the venture ecosystem.
For institutional VCs tracking the market, Singerman's moves are always worth monitoring. His pattern recognition has been consistently ahead of market consensus. His decision to leave Founders Fund and launch GPx is a signal that the venture capital industry is entering a new phase. Understanding what he's betting on now is a way to understand where capital will flow in the future.
One of the most significant aspects of GPx is Peter Thiel's backing. Thiel is not just an investor; he's a thought leader in venture capital who has consistently been ahead of market trends. His backing of GPx signals that the fund's thesis resonates with one of the most successful venture investors of all time.
Thiel's involvement also brings credibility and network effects. Thiel has relationships with founders, other investors, and policymakers across multiple domains. His endorsement of GPx and Singerman's thesis will likely attract both deal flow and limited partner capital.
This partnership also reflects a broader alignment in investment philosophy. Both Singerman and Thiel have been willing to bet on contrarian theses-frontier technology, defense, and hard problems-when conventional wisdom suggested these areas were either too risky or too niche. Their collaboration in GPx suggests they see significant opportunities in these areas in the coming years.
Brian Singerman's departure from Founders Fund and launch of GPx represents a significant moment in venture capital history. It signals the end of one era-the era of mega-funds controlling the majority of deal flow-and the beginning of another, characterized by more distributed capital, emerging fund managers, and increased focus on frontier technology.
For founders, operators, and investors, the implications are clear. The venture capital landscape is changing. Capital is becoming more distributed. Investors are increasingly specialized. And the best opportunities will go to founders who understand these shifts and can articulate how their companies fit into the emerging landscape.
Singerman's track record suggests he will continue to be ahead of these trends. His early bets on Airbnb, Stripe, and SpaceX were all contrarian at the time they were made. His more recent conviction in defense tech and healthcare innovation reflects his ability to identify structural shifts before they become obvious. GPx is positioned to continue this pattern, backing both frontier technology companies and the emerging fund managers who will shape the venture ecosystem in the coming years.
For the AI native platform for capital raising, Singerman's moves are a reminder of the importance of understanding investor thesis, building for the long term, and solving real problems in large markets. These principles have guided the most successful venture investments of the past two decades, and they will likely continue to guide the most successful investments of the next two decades.
The venture capital industry is entering a new phase. Understanding what Singerman is betting on now is a way to understand where that phase is headed.
Capitaly is the AI native platform for capital raising: a shared investor inbox, CRM, deal room, and pipeline, with always on AI agents that help you run the whole raise from one place.